Abstract Correction
There was an error in the abstract of the original publication [1]. The original publication states: “Overall, for inflammatory bowel disease, the pooled sensitivity, specificity, and AUC were 90% (95% CI, 85–93%), 76% (95% CI, 56–90%), and 0.92 (95% CI, 0.94–0.97), respectively”. A correction has been made in the abstract as follows:
“Overall, for inflammatory bowel disease, the pooled sensitivity, specificity, and AUC were 90% (95% CI, 85–93%), 76% (95% CI, 56–90%), and 0.92 (95% CI, 0.87–0.97), respectively”.
Text Correction
There was an error in Section 3.5, paragraph 2 in the original publication [1]. The original publication states: “An overall area under the curve (AUC) of 0.92 (95% CI, 0.94–0.97) indicates high diagnostic accuracy of CCE for IBD (see Figure 3)”. A correction has been made as follows:
“An overall area under the curve (AUC) of 0.92 (95% CI, 0.87–0.97) indicates high diagnostic accuracy of CCE for IBD (see Figure 3)”.
Error in Table 1
In the original publication [1], there was a mistake in Table 1: 0.92 (0.94–0.97). The corrected Table 1 appears below.
Table 1.
Overall and subgroup analysis for the diagnostic accuracy of CCE in IBD using a generalised linear mixed model (GLMM).
Table 1.
Overall and subgroup analysis for the diagnostic accuracy of CCE in IBD using a generalised linear mixed model (GLMM).
| Overall and Subgroup Analysis | Pooled Sensitivity (95% CI) | Pooled Specificity (95% CI) | Pooled PLR (95% CI) | Pooled NLR (95% CI) | Pooled DOR (95% CI) | SROC-AUC (95% CI) |
|---|---|---|---|---|---|---|
| IBD overall (n = 13) | 0.90 (0.85–0.93) | 0.76 (0.56–0.90) | 5.43 (5.39–5.46) | 0.107 (0.106–0.108) | 50.79 (50.27–51.30) | 0.92 (0.87–0.97) |
| No prokinetics (n = 3) | 0.87 (0.77–0.93) | 0.71 (0.27–0.94) | 3.04 (−1.07–7.13) | 0.18 (0.058–0.31) | 16.64 (−14.10–47.37) | NA (n < 5) |
| Metoclopramide (n = 4) | 0.93 (0.89–0.96) | 0.76 (0.58–0.88) | 3.86 (1.50–6.22) | 0.09 (0.051–0.13) | 42.92 (10.88–74.95) | NA (n < 5) |
| Domperidone (n = 4) | 0.91 (0.84–0.95) | 0.93 (0.71–0.99) | 13.33 (−7.89–34.56) | 0.099 (0.044–0.15) | 134.67 (−108.65–377.99) | NA (n < 5) |
| UC pooled (n = 7) | 0.92 (0.88–0.95) | 0.71 (0.35–0.92) | 3.19 (−0.24–6.62) | 0.11 (0.049–0.16) | 30.16 (−14.11–74.43) | 0.93 (0.89–0.97) |
| CCE1 capsule (n = 4) | 0.89 (0.82–0.93) | 0.46 (0.44–0.94) | 1.64 (−0.54–3.83) | 0.24 (−0.16–0.64) | 6.89 (−13.61–27.38) | NA (n < 5) |
| CCE2 capsule (n = 4) | 0.95 (0.86–0.98) | 0.93 (0.17–0.99) | 14.54 (−42.6–7.17) | 0.052 (0.0078–0.096) | 279.62 (−859.73–1419) | NA (n < 5) |
| CD pooled (n = 6) | 0.90 (0.85–0.93) | 0.88 (0.83–0.91) | 7.30 (4.90–9.69) | 0.11 (0.061–0.16) | 65.75 (30.96–100.55) | 0.87 (0.76–0.98) |
| CCE2 capsule (n = 4) | 0.88 (0.79–0.93) | 0.90 (0.84–0.93) | 8.74 (5.16–12.31) | 0.13 (0.056–0.21) | 66.45 (18.34–114.56) | NA (n < 5) |
| Crohn’s capsule (n = 2) | 0.93 (0.88–0.96) | 0.85 (0.76–0.91) | 6.07 (3.21–8.92) | 0.08 (0.032–0.13) | 75.5 (11.45–139.47) | NA (n < 5) |
| CD colitis (n = 6) | 0.85 (0.77–0.90) | 0.90 (0.86–0.94) | 8.93 (5.19–12.68) | 0.17 (0.093–0.24) | 54.85 (17.93–89.76) | 0.86 (n = too small) |
| CD terminal ileitis (n = 5) | 0.95 (0.90–0.97) | 0.84 (0.76–0.89) | 5.89 (3.49–8.29) | 0.059 (0.018–0.10) | 99.18 (12.95–185.40) | 0.95 (n = too small) |
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Lei, I.I.; Thorndal, C.; Manzoor, M.S.; Parsons, N.; Noble, C.; Huhulea, C.; Koulaouzidis, A.; Arasaradnam, R.P. The Diagnostic Accuracy of Colon Capsule Endoscopy in Inflammatory Bowel Disease—A Systematic Review and Meta-Analysis. Diagnostics 2024, 14, 2056. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).